Пермский государственный фармацевтический институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пермский государственный фармацевтический институтfiledCriticalПермский государственный фармацевтический институт
Priority to SU4253611/04ApriorityCriticalpatent/SU1455603A1/en
Application grantedgrantedCritical
Publication of SU1455603A1publicationCriticalpatent/SU1455603A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
FIELD: medicine. SUBSTANCE: desired product is prepared of hydrazide of anthranyl acid and maleic anhydride. Reaction is carried out in ethylacetate medium at yield 89 Essential formula of desired product is CHNO, its melting point being 162-164 C. LDof desired product is 1500, its antidepression effect being 31.6% at dose 10 mg/kg. EFFECT: creates novel compound having antidepressive action with improved activity and lower toxicity. 1 tbl
SU4253611/04A1987-06-011987-06-01O-aminobenzoyl hydrazide of maleic acid having antidepression activity
SU1455603A1
(en)
Amide of (1,2,4-triazino[5,6-b]indolyl-3-thio)acetic acid which accelerates processes of reduction after physical load and has activity against hypoxia